Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
MediciNova, Inc.
Focuses on acquiring and developing novel, small-molecule therapeutics for the US market
La Jolla, CA
NASDAQ: MNOV
Contact:
Jeff Himawan
www.medicinova.com
Related News
Medicinova Gets Green Light for MS Trial
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.
Chinese Joint Venture Completed
Joint Venture Announced: MediciNova, Inc. and Zhejiang Medicine Co., Ltd. to Partner in China
